Browse by UCL people
Group by: Type | Date
Jump to: Article | Conference item
Number of items: 11.
Article
Chataway, J;
De Angelis, F;
Connick, P;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
... MS-SMART Investigators; + view all
(2020)
Efficacy of three neuroprotective drugs in secondary
progressive multiple sclerosis (MS-SMART): a phase 2b,
multiarm, double-blind, randomised placebo-controlled trial.
The Lancet Neurology
10.1016/S1474-4422(19)30485-5.
(In press).
|
 |
|
Connick, P;
De Angelis, F;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
Stutters, J;
... UK Multiple Sclerosis Society Clinical Trials Network; + view all
(2018)
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
BMJ Open
, 8
, Article e021944. 10.1136/bmjopen-2018-021944.
|
|
|
De Angelis, F;
Connick, P;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
Stutters, J;
... Chataway, J; + view all
(2020)
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT.
Efficacy and Mechanism Evaluation
, 7
(3)
pp. 1-72.
10.3310/eme07030.
|
|
|
De Angelis, F;
John, NA;
Brownlee, WJ;
(2018)
Disease-modifying therapies for multiple sclerosis.
The BMJ
, 363
, Article k4674. 10.1136/bmj.k4674.
|
|
|
John, N;
Carroll, A;
Brownlee, WJ;
Chataway, J;
(2019)
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.
[Letter].
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320687.
(In press).
|
|
|
Lynch, DS;
Wade, C;
Paiva, ARBD;
John, N;
Kinsella, JA;
Merwick, Á;
Ahmed, RM;
... Chataway, J; + view all
(2019)
Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(5)
pp. 543-554.
10.1136/jnnp-2018-319481.
|
|
O'Herlihy, F;
John, NA;
Li, V;
Porter, B;
Lyons, L;
Rakusa, M;
Curtis, C;
... Chataway, J; + view all
(2019)
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm.
[Rapid communication].
Journal of the Neurological Sciences
, 407
, Article 116456. 10.1016/j.jns.2019.116456.
|
|
Porter, B;
John, NA;
Brenner, R;
Wilson, HC;
Turner, B;
Chataway, J;
(2019)
Urinary tract infection in multiple sclerosis: closing an audit loop by co-design and innovation.
British Journal of Neuroscience Nursing
, 15
(1)
10.12968/bjnn.2019.15.1.20.
|
|
Solanky, BS;
John, NA;
DeAngelis, F;
Stutters, J;
Prados, F;
Schneider, T;
Parker, RA;
... MS-SMART Investigators, ./; + view all
(2020)
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
American Journal of Neuroradiology
10.3174/ajnr.A6809.
(In press).
|
|
Williams, T;
Houlden, H;
Murphy, E;
John, N;
Fox, NC;
Schott, JM;
Adams, M;
... Lynch, DS; + view all
(2020)
How to diagnose difficult white matter disorders.
Practical Neurology
10.1136/practneurol-2020-002530.
(In press).
|
|
Conference item
|
Monteverdi, A;
Solanky, B;
De Angelis, F;
Plantone, D;
Stutters, J;
John, N;
Casiraghi, L;
... MS-SMART trialists; + view all
(2018)
Exploring metabolite profiling of patients with secondary progressive multiple sclerosis.
Presented at: ISMRM 2018, Paris, France.
|
|
